Posted by admin on May 27th, 2022

DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) declared a quarterly dividend on Friday, May 27th, RTT News reports. Stockholders of record on Friday, June 24th will be given a dividend of 0.125 per share by the medical instruments supplier on Friday, July 8th. This represents a $0.50 annualized dividend and a dividend yield of 1.28%.

DENTSPLY SIRONA has raised its dividend payment by an average of 7.1% per year over the last three years and has raised its dividend every year for the last 12 years. DENTSPLY SIRONA has a payout ratio of 18.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect DENTSPLY SIRONA to earn $2.66 per share next year, which means the company should continue to be able to cover its $0.50 annual dividend with an expected future payout ratio of 18.8%.

Shares of NASDAQ:XRAY opened at $38.95 on Friday. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The company’s 50-day moving average price is $43.72 and its 200 day moving average price is $50.03. The company has a market cap of $8.39 billion, a PE ratio of 23.05 and a beta of 0.94. DENTSPLY SIRONA has a fifty-two week low of $35.00 and a fifty-two week high of $67.69.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The firm had revenue of $9.67 billion during the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The firm’s quarterly revenue was up 841.1% on a year-over-year basis. During the same period last year, the company posted $0.72 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA will post 2.41 EPS for the current year.

In other news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total value of $273,999.00. Following the sale, the director now directly owns 35,155 shares of the company’s stock, valued at $1,396,005.05. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.76% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently modified their holdings of XRAY. Wellington Management Group LLP lifted its position in shares of DENTSPLY SIRONA by 83.1% in the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after acquiring an additional 2,497,773 shares during the period. Vanguard Group Inc. raised its stake in DENTSPLY SIRONA by 2.0% during the first quarter. Vanguard Group Inc. now owns 24,333,490 shares of the medical instruments supplier’s stock worth $1,197,694,000 after acquiring an additional 477,563 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in DENTSPLY SIRONA by 149.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 536,600 shares of the medical instruments supplier’s stock valued at $26,411,000 after purchasing an additional 321,674 shares during the last quarter. Worldquant Millennium Advisors LLC acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $12,912,000. Finally, Renaissance Technologies LLC increased its stake in shares of DENTSPLY SIRONA by 90.7% in the first quarter. Renaissance Technologies LLC now owns 381,058 shares of the medical instruments supplier’s stock valued at $18,756,000 after buying an additional 181,200 shares in the last quarter. Hedge funds and other institutional investors own 94.79% of the company’s stock.

A number of brokerages have recently commented on XRAY. Morgan Stanley cut their price objective on DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating for the company in a research report on Wednesday, April 20th. HC Wainwright decreased their price target on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a research report on Friday, April 22nd. Piper Sandler reissued a “neutral” rating and issued a $46.00 price target (down previously from $71.00) on shares of DENTSPLY SIRONA in a research note on Wednesday, April 20th. Credit Suisse Group decreased their target price on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an “outperform” rating for the company in a report on Tuesday, March 1st. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Thursday. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $52.89.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Canadian Imperial Bank of Commerce (NYSE:CM) Releases Earnings Results, Misses Estimates By $1.15 EPS

Analysts’ Recent Ratings Changes for Home Depot (HD)